BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27239314)

  • 41. A case of treatment-induced neuropathy in an adolescent with type 1 diabetes.
    Varadharaju N; Jeevarathnam D; Rajan M; Ponnurangam Nagarajan V; James S
    Ann Pediatr Endocrinol Metab; 2019 Sep; 24(3):203-206. PubMed ID: 31607115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of Charcot Arthropathy in Type 2 Diabetes Patients Aged over 50 Years with Severe Peripheral Neuropathy: A Retrospective Study in a Tertiary Care South Indian Hospital.
    Salini D; Harish K; Minnie P; Sundaram KR; Arun B; Sandya CJ; Mangalanandan TS; Vivek L; Praveen VP
    Indian J Endocrinol Metab; 2018; 22(1):107-111. PubMed ID: 29535947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The association between foot-care self efficacy beliefs and actual foot-care behaviour in people with peripheral neuropathy: a cross-sectional study.
    Perrin BM; Swerissen H; Payne C
    J Foot Ankle Res; 2009 Feb; 2():3. PubMed ID: 19192309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Do Basic Neurologic Assessments Tell Us More Than We Realize?
    Donnan L; Baker E; Horn A; Robinson C
    J Am Podiatr Med Assoc; 2023; 113(5):. PubMed ID: 37934588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Special foot clinics for patients with diabetes.
    Sibbald RG; Kensholme A; Carter L
    J Wound Care; 1996 May; 5(5):238-241. PubMed ID: 27935756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Section 12: Retinopathy, Neuropathy, and Foot Care.
    Clin Diabetes; 2024; 42(2):214-215. PubMed ID: 38666197
    [No Abstract]   [Full Text] [Related]  

  • 47. Assessing the vibration perception threshold in a community sample of adult Ghanaians.
    Djankpa FT; Amoah AGB; Adzaku FK; Aidoo E; Boateng I
    PLoS One; 2023; 18(11):e0291606. PubMed ID: 37939073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Consensus clinical management guidelines for Alström syndrome.
    Tahani N; Maffei P; Dollfus H; Paisey R; Valverde D; Milan G; Han JC; Favaretto F; Madathil SC; Dawson C; Armstrong MJ; Warfield AT; Düzenli S; Francomano CA; Gunay-Aygun M; Dassie F; Marion V; Valenti M; Leeson-Beevers K; Chivers A; Steeds R; Barrett T; Geberhiwot T
    Orphanet J Rare Dis; 2020 Sep; 15(1):253. PubMed ID: 32958032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetic foot ulcer incidence and survival with improved diabetic foot services: an 18-year study.
    Paisey RB; Abbott A; Paisey CF; Walker D
    Diabet Med; 2019 Nov; 36(11):1424-1430. PubMed ID: 31150130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Letter: The Necessity of the Simple Tests for Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus Patients without Neuropathic Symptoms in Clinical Practice (
    Hong JH
    Diabetes Metab J; 2018 Dec; 42(6):544-545. PubMed ID: 30565443
    [No Abstract]   [Full Text] [Related]  

  • 51. Diabetic neuropathy and foot complications.
    Boulton AJ
    Handb Clin Neurol; 2014; 126():97-107. PubMed ID: 25410217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What you can't feel can hurt you.
    Boulton AJ
    J Vasc Surg; 2010 Sep; 52(3 Suppl):28S-30S. PubMed ID: 20804930
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of protective sensory loss, neuropathy and foot ulceration in type 2 diabetes.
    Paisey RB; Darby T; George AM; Waterson M; Hewson P; Paisey CF; Thomson MP
    BMJ Open Diabetes Res Care; 2016; 4(1):e000163. PubMed ID: 27239314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration.
    Armstrong DG; Lavery LA; Vela SA; Quebedeaux TL; Fleischli JG
    Arch Intern Med; 1998 Feb; 158(3):289-92. PubMed ID: 9472210
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry.
    Oguejiofor OC; Odenigbo CU; Oguejiofor CB
    Niger J Clin Pract; 2010 Sep; 13(3):240-7. PubMed ID: 20857777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of risk factors for foot ulceration in patients with end-stage renal disease on haemodialysis.
    Kaminski M; Frescos N; Tucker S
    Intern Med J; 2012 Jun; 42(6):e120-8. PubMed ID: 21999812
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.